Safety and tolerability were assessed through reported adverse events (AEs), hypoglycaemic episodes (defined as confirmed if the episode was severe according to the American Diabetes Association [ADA], i.e
It does so by binding to harmful substances and facilitating their elimination
Symptoms, physical examination, family history, cardiovascular-risk calculations, electrocardiography, imaging, and other evaluations may still be needed
Semaglutide affects central appetite pathways primarily through activation of receptors in the area postrema and other circumventricular organs, with additional effects mediated via vagal signaling pathways
Ensuring affordability remains a priority, particularly as the global prevalence of chronic conditions such as obesity and diabetes continues to rise